Related Experiment Videos
Berberine inhibits human neuroblastoma cell growth through induction of p53-dependent apoptosis
Myoung Suk Choi1, Dong Yeon Yuk, Ju Hoon Oh
1College of Pharmacy Medical Science and Engineering Research Center, Chungbuk National University 12, Gaeshin-dong, Heungduk-gu, Cheongju, Chungbuk 361-763, Korea.
Abstract:
Berberine, an alkaloid, has anti-tumor properties in some cancer cells, but action mechanisms are not clear yet. We here investigated the anticancer activity of berberine and possible mechanisms in human neuroblastoma SK-N-SH and SK-N-MC cells. The p53-expressing cells, SK-N-SH (IC50=37 microM) were more susceptible to berberine than the p53-deficient cells, SK-N-MC (IC50 > or =100 microM) without cytotoxic effect on the cortical neuronal cells. Berberine caused cell cycle arrest in G0/G1 phase and apoptotic cell death, and these effects were much greater in SK-N-SH cells than those in SK-N-MC cells. Berberine much greatly decreased G0/G1 phase-associated cyclin and cyclin-dependent kinase (cyclin D1, cyclin E, Cdk2, and Cdk4) expression, and increased apoptotic gene expression and activation of caspase-3 in SK-N-SH cells. Exploration of p53 siRNA or pifithrin-alpha (PFT-alpha), a p53 inhibitor, in the SK-N-SH cells resulted in increase of IC50 values for cell viability, and decreased apoptotic cell death, expression of p53 and activation of caspase-3. Therefore, these results showed that berberine causes p53-dependent apoptotic death of neuroblastoma cells, and suggested that berberine may be useful as an anticancer agent for neuroblastoma.
Insights
Berberine shows anticancer effects against neuroblastoma cells by inducing p53-dependent apoptosis. This natural compound may serve as a potential therapeutic agent for neuroblastoma treatment.
Area of Science:
- Pharmacology
- Oncology
- Molecular Biology
Background:
- Berberine, a natural alkaloid, exhibits anti-tumor properties in various cancer cells.
- The precise mechanisms underlying berberine's anticancer activity remain incompletely understood.
Purpose of the Study:
- To investigate the anticancer effects of berberine on human neuroblastoma cell lines (SK-N-SH and SK-N-MC).
- To elucidate the molecular mechanisms involved in berberine-induced cell death, particularly focusing on the role of p53.
Main Methods:
- Cell viability assays (IC50 determination) were performed on neuroblastoma and cortical neuronal cells.
- Cell cycle progression and apoptosis were analyzed using flow cytometry.
- Expression levels of cell cycle regulators (cyclins, CDKs) and apoptosis-related genes were assessed.
- The role of p53 was investigated using p53 siRNA and a p53 inhibitor (pifithrin-alpha).
Main Results:
- Berberine demonstrated higher susceptibility in p53-expressing SK-N-SH cells (IC50=37 microM) compared to p53-deficient SK-N-MC cells (IC50 > or =100 microM).
- Berberine induced G0/G1 cell cycle arrest and apoptotic cell death, with more pronounced effects in SK-N-SH cells.
- Berberine decreased the expression of cyclin D1, cyclin E, Cdk2, and Cdk4, while increasing apoptotic gene expression and caspase-3 activation in SK-N-SH cells.
- Inhibition of p53 function led to increased cell viability and reduced berberine-induced apoptosis and caspase-3 activation.
Conclusions:
- Berberine induces p53-dependent apoptotic death in human neuroblastoma cells.
- The findings suggest that berberine's anticancer mechanism involves the regulation of cell cycle progression and apoptosis via a p53-mediated pathway.
- Berberine holds potential as a therapeutic agent for neuroblastoma.
Related Concept Videos
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
Negative Regulator Molecules
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Inhibition of Cdk Activity
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...